Company intelligence / Profile preview

BioTesserae

Charlottesville, Virginia, United Statesbiotesserae.com ↗

Ownership: Private
Development stage: Other

Overview

BioTesserae is a synthetic biology company specializing in the development of DNA-based molecular tagging and diagnostic solutions. The company leverages proprietary technology to create molecular barcodes that can be used for secure supply chain tracking, forensic identification, and rapid point-of-care diagnostics. By integrating advanced microfluidics with synthetic DNA sequences, BioTesserae provides high-resolution authentication and pathogen detection capabilities. Their platform is designed to address critical needs in biosecurity, healthcare, and industrial anti-counterfeiting.

Therapeutic areas: OtherInfectious Diseases
Modalities: Synthetic DNAMicrofluidics
Industry: Molecular Diagnostics

Partnerships

University of Virginia

Beyond the preview

Go deeper on BioTesserae.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioTesserae.

Explore the full profile